Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee.

Am J Transplant. 2014 Feb;14(2):272-83. doi: 10.1111/ajt.12590. Erratum in: Am J Transplant. 2015 Oct;15(10):2784. Rangel, Erika [corrected to Rangel, Erika B].

2.

An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts.

Haas M.

Curr Opin Organ Transplant. 2014 Jun;19(3):315-22. doi: 10.1097/MOT.0000000000000072. Review.

PMID:
24811440
3.

Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts.

Haas M.

Curr Opin Nephrol Hypertens. 2018 May;27(3):137-143. doi: 10.1097/MNH.0000000000000398. Review.

PMID:
29300203
4.

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M.

Am J Transplant. 2017 Jan;17(1):28-41. doi: 10.1111/ajt.14107.

5.

Significance of C4d deposition in antibody-mediated rejection.

Takeda A, Otsuka Y, Horike K, Inaguma D, Hiramitsu T, Yamamoto T, Nanmoku K, Goto N, Watarai Y, Uchida K, Morozumi K, Kobayashi T.

Clin Transplant. 2012 Jul;26 Suppl 24:43-8. doi: 10.1111/j.1399-0012.2012.01642.x.

PMID:
22747475
6.

Banff 2013 update: Pearls and pitfalls in transplant renal pathology.

Hara S.

Nephrology (Carlton). 2015 Jul;20 Suppl 2:2-8. doi: 10.1111/nep.12474. Review.

PMID:
26031578
7.

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

Demetris AJ, Bellamy C, Hübscher SG, O'Leary J, Randhawa PS, Feng S, Neil D, Colvin RB, McCaughan G, Fung JJ, Del Bello A, Reinholt FP, Haga H, Adeyi O, Czaja AJ, Schiano T, Fiel MI, Smith ML, Sebagh M, Tanigawa RY, Yilmaz F, Alexander G, Baiocchi L, Balasubramanian M, Batal I, Bhan AK, Bucuvalas J, Cerski CTS, Charlotte F, de Vera ME, ElMonayeri M, Fontes P, Furth EE, Gouw ASH, Hafezi-Bakhtiari S, Hart J, Honsova E, Ismail W, Itoh T, Jhala NC, Khettry U, Klintmalm GB, Knechtle S, Koshiba T, Kozlowski T, Lassman CR, Lerut J, Levitsky J, Licini L, Liotta R, Mazariegos G, Minervini MI, Misdraji J, Mohanakumar T, Mölne J, Nasser I, Neuberger J, O'Neil M, Pappo O, Petrovic L, Ruiz P, Sağol Ö, Sanchez Fueyo A, Sasatomi E, Shaked A, Shiller M, Shimizu T, Sis B, Sonzogni A, Stevenson HL, Thung SN, Tisone G, Tsamandas AC, Wernerson A, Wu T, Zeevi A, Zen Y.

Am J Transplant. 2016 Oct;16(10):2816-2835. doi: 10.1111/ajt.13909. Epub 2016 Jul 14.

8.

C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.

Banasik M, Boratyńska M, Nowakowska B, Haloń A, Kościelska-Kasprzak K, Drulis-Fajdasz D, Patrzałek D, Weyde W, Klinger M.

Transplant Proc. 2007 Nov;39(9):2718-20.

PMID:
18021967
9.

Emerging Concepts and Controversies in Renal Pathology: C4d-Negative and Arterial Lesions as Manifestations of Antibody-Mediated Transplant Rejection.

Haas M.

Surg Pathol Clin. 2014 Sep;7(3):457-67. doi: 10.1016/j.path.2014.04.003. Epub 2014 Jun 25. Review.

PMID:
26837450
10.

Clinical and pathological analyses of transplant glomerulopathy cases.

Shimizu T, Ishida H, Toki D, Nozaki T, Omoto K, Tanabe K, Honda K, Koike J.

Nephrology (Carlton). 2014 Jun;19 Suppl 3:21-6. doi: 10.1111/nep.12243.

PMID:
24842817
11.

Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.

Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB.

J Am Soc Nephrol. 2002 Mar;13(3):779-87.

12.

Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.

Kikić Ž, Kainz A, Kozakowski N, Oberbauer R, Regele H, Bond G, Böhmig GA.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1435-43. doi: 10.2215/CJN.09901014. Epub 2015 Jun 12.

13.

Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.

Ali S, Ormsby A, Shah V, Segovia MC, Kantz KL, Skorupski S, Eisenbrey AB, Mahan M, Huang MA.

Transpl Immunol. 2012 Jan;26(1):62-9. doi: 10.1016/j.trim.2011.08.005. Epub 2011 Sep 1.

PMID:
21907804
14.

A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.

Sadaka B, Ejaz NS, Shields AR, Cardi MA, Wadih G, Witte D, Abu Jawdeh BG, Alloway RR, Woodle ES.

Transplantation. 2015 Aug;99(8):1691-9. doi: 10.1097/TP.0000000000000694.

PMID:
25803498
15.

Banff 2011 Meeting report: new concepts in antibody-mediated rejection.

Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Cendales L, Demetris AJ, Drachenberg CB, Farver CF, Rodriguez ER, Wallace WD, Glotz D; Banff meeting report writing committee.

Am J Transplant. 2012 Mar;12(3):563-70. doi: 10.1111/j.1600-6143.2011.03926.x. Epub 2012 Feb 2.

16.

Clinicopathological analysis of acute vascular rejection cases after renal transplantation.

Shimizu T, Ishida H, Shirakawa H, Omoto K, Tsunoyama K, Tokumoto T, Tanabe K.

Clin Transplant. 2010 Jul;24 Suppl 22:22-6. doi: 10.1111/j.1399-0012.2010.01277.x.

PMID:
20590689
17.

Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.

Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C.

Kidney Int. 2017 Sep;92(3):729-742. doi: 10.1016/j.kint.2017.03.033. Epub 2017 May 26.

PMID:
28554738
18.
19.

Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum.

Haas M.

Curr Opin Nephrol Hypertens. 2012 May;21(3):264-71. doi: 10.1097/MNH.0b013e3283520efa. Review.

PMID:
22388553
20.

Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?

Satoskar AA, Lehman AM, Nadasdy GM, Sedmak DD, Pesavento TE, Henry ML, Pelletier RP, Ferguson RM, Nadasdy T.

Clin Transplant. 2008 Jan-Feb;22(1):61-7. doi: 10.1111/j.1399-0012.2007.00745.x.

PMID:
18217907

Supplemental Content

Support Center